Compulsory License India

Compulsory License season now.

Indian companies started exploring CL as an option to market drugs which are patented in India. (Whichever product patents granted on 2007-2008, are subject of CL now)

Product/Innovator Indian Patent No Date of Grant Applied by
Maraviroc/Pfizer 204132 (885/MUM/1999) 28/03/2007 Natco
Sorafenib/ Bayer 215758 (IN/PCT/2001/799/MUM) 28/03/2008 Natco is awardedCL for sorafenib
Raltegravir/Merck 212400 (868/CHENP/2004) 15/02/2008 Cipla

This list will be updated, as and when there is some news available.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s